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Abstract
A GGGGCC hexanucleotide repeat expansion in the C9orf72 gene is
the most common genetic cause of amyotrophic lateral sclerosis
and frontotemporal dementia (C9ALS/FTD). C9orf72 encodes two
C9orf72 protein isoforms of unclear function. Reduced levels of
C9orf72 expression have been reported in C9ALS/FTD patients, and
although C9orf72 haploinsufficiency has been proposed to contri-
bute to C9ALS/FTD, its significance is not yet clear. Here, we report
that C9orf72 interacts with Rab1a and the Unc-51-like kinase 1
(ULK1) autophagy initiation complex. As a Rab1a effector, C9orf72
controls initiation of autophagy by regulating the Rab1a-dependent
trafficking of the ULK1 autophagy initiation complex to the
phagophore. Accordingly, reduction of C9orf72 expression in cell
lines and primary neurons attenuated autophagy and caused accu-
mulation of p62-positive puncta reminiscent of the p62 pathology
observed in C9ALS/FTD patients. Finally, basal levels of autophagy
were markedly reduced in C9ALS/FTD patient-derived iNeurons. Thus,
our data identify C9orf72 as a novel Rab1a effector in the regulation
of autophagy and indicate that C9orf72 haploinsufficiency and associ-
ated reductions in autophagy might be the underlying cause of
C9ALS/FTD-associated p62 pathology.
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Introduction
Macroautophagy (hereafter termed autophagy) is a conserved lyso-
somal degradation pathway that is an essential process to maintain
cellular homeostasis. A double lipid membrane, the phagophore,
engulfs cellular components targeted for degradation including
proteins and organelles. The resulting autophagosome fuses with
lysosomes, and its content is degraded to release cell components
that can be reused. Autophagy is induced in response to starvation
to boost nutrient availability, but is also responsible for the
removal of defunct, damaged organelles and misfolded/aggregated
proteins. Defects in autophagy are linked with several human
diseases, including neurological disorders such as Parkinson’s
disease and amyotrophic lateral sclerosis (ALS) (Harris &
Rubinsztein, 2012).
A GGGGCC hexanucleotide repeat expansion in intron 1 of the
C9orf72 gene was found to be a common cause of both ALS and
frontotemporal dementia (FTD) (DeJesus-Hernandez et al, 2011;
Renton et al, 2011), accounting for approximately 40 and 25% of
familial ALS and FTD, respectively, and approximately 6% of
sporadic ALS (Majounie et al, 2012). C9ALS/FTD cases are distin-
guished from other ALS and FTD cases by specific ubiquitin and
p62-positive but TDP-43-negative, neuronal cytoplasmic and
intranuclear inclusions in the cerebellum and hippocampus
(Al-Sarraj et al, 2011; Cooper-Knock et al, 2012; Mackenzie et al,
2014).
Reduced levels of C9orf72 mRNA have been reported in post-
mortem tissue, patient-derived lymphoblast cell lines and iPSNs and
in blood samples (DeJesus-Hernandez et al, 2011; Cooper-Knock
et al, 2012; Gijselinck et al, 2012, 2015; Belzil et al, 2013; Ciura
et al, 2013; Donnelly et al, 2013; Mori et al, 2013b; Xi et al, 2013)
and reduced C9orf72 protein levels were detected in the frontal
cortex of ALS and FTD cases (Waite et al, 2014; Xiao et al, 2015),
suggesting haploinsufficiency may contribute to C9ALS/FTD by a
loss-of-function mechanism. In addition, the pathogenic mechanism
may involve a toxic gain of function via RNA toxicity (DeJesus-
Hernandez et al, 2011; Donnelly et al, 2013; Lagier-Tourenne et al,
2013; Mizielinska et al, 2013; Mori et al, 2013b; Sareen et al, 2013;
Zu et al, 2013) and/or repeat-associated non-ATG (RAN) translation
of the repeats into aggregation-prone dipeptide-repeat (DPR)
proteins (Ash et al, 2013; Gendron et al, 2013; Mori et al, 2013a,b;
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Zu et al, 2013; Mizielinska et al, 2014). Possibly all three mecha-
nisms contribute to the pathogenesis of C9ALS/FTD in a multiple-
hit fashion.
Alternative splicing of C9orf72 is predicted to yield three mRNAs
that code for two C9orf72 isoforms, a 481 amino acid (aa) isoform
of approximately 50 kDa, C9orf72L (aa 1–481) and a 222 aa, 25 kDa
isoform, C9orf72S (aa 1–221), respectively (DeJesus-Hernandez
et al, 2011). Data from C9orf72 knockout mice have shown that
C9orf72 is required for macrophage and microglial function in vivo
(Atanasio et al, 2016; O’Rourke et al, 2016; Sudria-Lopez et al,
2016; Sullivan et al, 2016), but the neuronal function of C9orf72
remains unclear. It has been suggested that C9orf72 regulates endo-
somal/lysosomal trafficking via Rab GTPases, but details are lacking
(Farg et al, 2014). Alternatively, C9orf72 may be involved in nucleo-
cytoplasmic shuttling (Xiao et al, 2015). Bioinformatics analysis
revealed that C9orf72 shows structural homology to the Differen-
tially Expressed in Normal and Neoplasia (DENN) family of proteins
which function as GDP/GTP exchange factors (GEF) of Rab GTPases
(Zhang et al, 2012; Levine et al, 2013).
Here, we show that C9orf72 is a Rab1a effector that controls initi-
ation of autophagy by regulating the Rab1a-dependent trafficking of
the ULK1 autophagy initiation complex to the phagophore. Disrup-
tion of C9orf72 function in cell lines and primary neurons inhibited
autophagy and caused p62 accumulation similar to the specific
pathology observed in C9ALS/FTD patients. Furthermore, basal
autophagy levels were reduced in C9ALS/FTD patient-derived
iNeurons. Together, these findings identify a novel function of
C9orf72 and suggest a possible role for autophagy deficits by
C9orf72 haploinsufficiency in C9ALS/FTD.
Results
C9orf72 regulates the initiation of autophagy
C9ALS/FTD patients show specific ubiquitin and p62-positive but
TDP-43-negative, neuronal cytoplasmic and intranuclear inclusions
in the cerebellum and hippocampus, which is indicative of impaired
autophagy (Al-Sarraj et al, 2011; Cooper-Knock et al, 2012; Mackenzie
et al, 2014). Because C9orf72 haploinsufficiency may contribute to
C9ALS/FTD by a loss-of-function mechanism, we hypothesized that
C9orf72 may be involved in autophagy.
To test this directly, we reduced the expression of both C9orf72
isoforms in HeLa or HEK293 cells using a pool of two siRNAs
directed against different regions of C9orf72, and in rat primary
cortical neurons using miRNA and determined the effect of C9orf72
depletion on autophagy by monitoring microtubule-associated
protein 1A/1B light chain 3 (LC3) flux (Spira et al, 1993). During
autophagy, the cytosolic form of LC3 (LC3-I) is lipidated to form
LC3-II, which is recruited to autophagosomal membranes. LC3-II
remains membrane associated throughout autophagy, and in the
process, it is degraded in autolysosomes. Thus, turnover of LC3-II
reflects the progression of autophagy. Due to questionable speci-
ficity of commercial C9orf72 antibodies, we used mRNA levels and
RT–qPCR to confirm C9orf72 knockdown throughout this study
(Appendix Fig S2). In mammalian cells, ULK1 controls the initial
stages of autophagosome formation and is itself regulated in
response to nutrient starvation by mammalian target of rapamycin
(mTOR) kinase. Therefore, inhibitors of mTOR such as rapamycin
and Torin1 are reliable experimental inducers of ULK1-dependent
autophagy (Thoreen et al, 2009).
HeLa cells treated with non-targeting control siRNA or C9orf72
siRNA were transfected with mCherry-EGFP-LC3, and autophagy
was induced using Torin1. We quantified the number of autophago-
somes and autolysosomes by counting mCherry-EGFP-LC3-positive
puncta by fluorescence microscopy. mCherry-EGFP-LC3 allows
distinction between autophagosomes and autolysosomes because
EGFP fluorescence is quenched by the low pH in autolysosomes
whereas mCherry fluorescence is not affected. Thus, autophago-
somes fluoresce both red and green, whereas autolysosomes appear
only red (Kimura et al, 2007; Pankiv et al, 2007). As expected,
Torin1 treatment caused a large increase in autophagosomes and a
more modest increase in autolysosomes in control siRNA-treated
cells. By contrast, in C9orf72 siRNA-treated cells no increase in
autophagosomes was observed after Torin1 treatment, and the
increase in autolysosomes was significantly reduced (Fig 1A). Thus,
C9orf72 siRNA appeared to interfere with the induction of auto-
phagy but not the later stages. To directly investigate this possibility,
we treated HeLa cells with bafilomycin A1, a V-ATPase inhibitor that
causes an increase in lysosomal pH and blocks fusion of autophago-
somes with lysosomes (Spira et al, 1993). Under these conditions,
counting autophagosomes allows specific quantification of the induc-
tion of autophagy (Tanida et al, 2005). In control siRNA-treated HeLa
cells incubated with bafilomycin A1, Torin1 treatment induced
Figure 1. C9orf72 regulates the initiation of autophagy.
A, B HeLa cells treated with non-targeting siRNA (Ctrl) or C9orf72 siRNA and transfected with mCherry-EGFP-LC3 were treated with vehicle (Ctrl), Torin1 (250 nM; 3 h),
bafilomycin A1 (BafA1, 100 nM; 6 h), or combinations thereof as indicated. Autophagosomes (green+red) and autolysosomes (red only) were quantified per cell
(mean  SEM from 3 independent experiments; one-way ANOVA with Fisher’s LSD test: ns, not significant, *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001; N
(cells) = Ctrl/Ctrl: 120; Ctrl/Torin1: 101; C9orf72/Ctrl: 99; C9orf72/Torin1: 106; Ctrl/BafA1: 116; Ctrl/Torin1/BafA1: 118; C9orf72/BafA1: 109; C9orf72/Torin1/BafA1: 106).
Scale bar = 20 lm. C9orf72 knockdown was confirmed by RT–qPCR (Appendix Fig S2).
C, D HEK293 cells treated with non-targeting (Ctrl) or C9orf72 siRNA were incubated with BafA1, BafA1 + Torin1 (C), or BafA1 + rapamycin (D), and levels of LC3-I and II
were determined by immunoblots. Levels of LC3-II were normalized against a-tubulin and are shown relative to the BafA1-treated sample (mean  SEM; one-way
ANOVA with Fisher’s LSD test: ns, not significant, *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001; N = 3 experiments).
E, F Primary cortical neurons (DIV5/6) were transfected with ECFP non-targeting (Ctrl) or C9orf72 miRNA (cyan) and EGFP-LC3 (green). Three days post-transfection,
neurons were treated with vehicle (Ctrl), Torin1 (250 nM; 3 h), BafA1 (100 nM; 5 h), or combinations thereof as indicated. Autophagosomes were quantified as the
number of EGFP-LC3-positive puncta per soma from 2 independent experiments (mean  SEM; one-way ANOVA with Fisher’s LSD test: ns, not significant,
*P ≤ 0.05; ***P ≤ 0.001; ****P ≤ 0.0001; N (cells) = Ctrl miRNA/Ctrl: 77; Ctrl miRNA/Torin1: 68; C9orf72 miRNA/Ctrl: 57; C9orf72 miRNA/Torin1: 69; Ctrl miRNA/BafA1:
35; Ctrl miRNA/Torin1/BafA1: 57; C9orf72 miRNA/BafA1: 66; C9orf72 miRNA/Torin1/BafA1: 64). Scale bar = 5 lm.
Source data are available online for this figure.
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autophagy and caused an increase in autophagosomes proportional to
the level of induction. Conversely, in C9orf72 siRNA-treated HeLa cells
no increase was detected (Fig 1B), indicating that loss of C9orf72
prevents induction of autophagy.
In a complementary approach, we quantified the levels of
endogenous LC3-II on immunoblots. In HEK293 cells treated with
non-targeting control siRNA, inhibition of mTOR with either Torin1
(Figs 1C and EV1A) or rapamycin (Figs 1D and EV1B) in the pres-
ence of bafilomycin A1 caused a marked increase in LC3-II levels
compared to control cells. However, consistent with inhibition of
autophagy initiation, LC3-II levels did not increase upon induction
of autophagy in HEK293 cells treated with C9orf72 siRNA (Fig 1C
and D), confirming the results obtained with mCherry-EGFP-LC3 in
HeLa cells. To confirm the specificity of the siRNAs, we also tested
the single siRNAs separately in this assay and found that both
siRNAs knocked down C9orf72 and inhibited initiation of autophagy
(Appendix Fig S1).
To assess whether loss of C9orf72 also affected induction of
autophagy in neurons, we co-transfected primary rat cortical
neurons with EGFP-LC3 and non-targeting control miRNA or
C9orf72 targeting miRNA and quantified the number of EGFP-LC3-
positive autophagosomes after treatment with Torin1 and/or bafilo-
mycin A1. Compared to non-treated controls, Torin1 treatment
caused an increase in autophagosomes in control miRNA-
transfected neurons but not in C9orf72 miRNA-transfected neurons
(Fig 1E). Similarly, in control miRNA expressing neurons incubated
with bafilomycin A1, Torin1 treatment induced autophagy and
caused an increase in autophagosomes, but this was not the case in
C9orf72 miRNA-transfected neurons (Fig 1F). Hence, loss of
C9orf72 also prevents induction of autophagy in primary neurons.
We next asked whether C9orf72 could induce autophagy and
whether this involved the ULK1 initiation complex. FAK family
kinase-interacting protein of 200 kDa (FIP200) forms a stable
complex with ULK1 and autophagy-related 13 (ATG13) in the ULK1
initiation complex and is essential for the initiation of autophagy.
Hence, FIP200 siRNA can be used to disrupt the ULK1 initiation
complex (Hara et al, 2008). We overexpressed C9orf72 in cells
treated with non-targeting or FIP200 siRNA and monitored induction
of autophagy by determining co-transfected EGFP-LC3 conversion
on immunoblots and by investigating the distribution of EGFP-LC3.
In control siRNA-treated cells, overexpression of either C9orf72S or
C9orf72L increased EGFP-LC3-II levels (Fig 2A) and correspondingly
the number of EGFP-LC3-positive autophagosomes increased
(Fig 2B). Loss of FIP200 completely prevented induction of autop-
hagy by expression of C9orf72 in both assays (Figs 2A and B). As
expected, FIP200 siRNA also completely prevented induction of
autophagy by Torin1 treatment (Fig 2B). Thus, C9orf72 overexpres-
sion induces autophagy via the ULK1 complex.
Together, these results reveal that C9orf72 regulates autophagy
initiation in cell lines and primary neurons via the ULK1 complex.
C9orf72 interacts with the ULK1 initiation complex
To further characterize the involvement of C9orf72 in autophagy
initiation, we investigated the interaction of C9orf72 with the ULK1
complex in co-immunoprecipitation assays. In a first approach,
HEK293 cells were transfected with Myc- or FLAG-tagged C9orf72S
or C9orf72L together with FLAG-FIP200, HA-ULK1, or Myc-ATG13
and C9orf72 was isolated using antibodies against the Myc or FLAG
tag. FLAG-FIP200, HA-ULK1, and Myc-ATG13 specifically co-
immunoprecipitated with C9orf72S and C9orf72L in these assays
(Figs 3A–C). Secondly, we immunoprecipitated transfected Myc-
tagged C9orf72S or C9orf72L and probed the resulting immune
pellet for endogenous FIP200, ULK1, and ATG13. All three endoge-
nous members of the ULK1 initiation complex were detected in the
C9orf72 immunoprecipitates (Fig 3D and E).
We next investigated the interaction of C9orf72 with the ULK1
initiation complex in situ by proximity ligation assay (PLA) (So¨derberg
et al, 2006) in HeLa cells transfected with HA-ULK1 or FLAG-
FIP200 and Myc-C9orf72 or with Myc-ATG13 and EGFP-C9orf72. Using
antibodies against the tags, we observed proximity signals in all
co-transfected cells examined (Figs 3F–H and EV2), confirming the
interaction of C9orf72 with the ULK1 initiation complex in intact cells.
As negative controls, we transfected HeLa cells with only C9orf72,
ULK1, FIP200, or ATG13 and found only very low numbers of
proximity signals.
To further characterize the interaction of C9orf72 with the ULK1
complex, we tested for interactions in in vitro binding assays. We
incubated recombinant GST-tagged C9orf72 with in vitro-translated
35S-radiolabeled FIP200-6xHis segments (aa 1–638, aa 639–1373,
and aa 1374–1591), HA-ULK1 or Myc-ATG13 and pulled down GST-
C9orf72 using glutathione beads. C9orf72S and C9orf72L bound
to the N-terminus of FIP200 (aa 1–638) but not the middle segment
aa 639–1373 (Fig 3I). The C-terminus of FIP200 (aa 1374–1591)
bound to C9orf72S and C9orf72L but also to the GST control, indi-
cating that this was not a specific interaction (Fig 3I). C9orf72S and
C9orf72L also interacted with ATG13 and ULK1 (Fig 3J and K).
Together, these data show that C9orf72 interacts with the ULK1
initiation complex by binding to ULK1, ATG13, and the N-terminus
of FIP200.
Loss of C9orf72 does not affect ULK1 activation
Under basal conditions, mTOR suppresses ULK1 activity by phos-
phorylating ULK1 at Ser757 (Kim et al, 2011). Inactivated mTOR is
released from the ULK1 complex and ULK1 Ser757 phosphorylation
is lost, thereby enhancing ULK1 kinase activity, which in turn phos-
phorylates ATG13 and FIP200 to initiate autophagy (Ganley et al,
2009; Jung et al, 2009; Kim et al, 2011). Thus, Ser757 phosphoryla-
tion of ULK1 is indicative of the activation state of the ULK1
complex. To investigate whether C9orf72 affected autophagy at the
level of ULK1 activation, we monitored ULK1 Ser757 phosphoryla-
tion using phosphospecific antibodies. Inhibition of mTOR by rapa-
mycin reduced phosphorylation of ULK1 on Ser757 in both control
and C9orf72 siRNA-treated HEK293 cells (Fig 4A). Thus, loss of
C9orf72 did not prevent activation of ULK1.
C9orf72 regulates translocation of the ULK1 complex to the
phagophore via Rab1a
The activated ULK1 complex translocates to the phagophore to initi-
ate autophagosome formation (Hara et al, 2008). To investigate
whether C9orf72 was involved in the translocation of the ULK1
complex to the phagophore, we monitored the translocation of
mCherry-FIP200 in HeLa cells and primary rat cortical neurons
treated with siRNA or transfected with miRNA to knock down
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C9orf72 expression, respectively. Under basal conditions, mCherry-
FIP200 was found diffusely in the cytoplasm with some bright
puncta observable in both control and C9orf72 knockdown HeLa
cells (Fig 4B) and rat cortical neurons (Fig 4C). When we induced
autophagy with Torin1, the number of mCherry-FIP200 puncta
increased significantly in control cells, consistent with translocation
of the ULK1 complex to the phagophore. In contrast, in C9orf72
knockdown cells and neurons, no increase above basal level was
observed after treatment with Torin1 (Fig 4B and C). To further
assert the specificity of this effect, we reintroduced C9orf72 into
C9orf72 miRNA-transfected rat cortical neurons by transfection with
human C9orf72. In these neurons, Torin1 treatment increased the
number of mCherry-FIP200 puncta, showing that human C9orf72
rescued the inhibition of ULK1 complex translocation (Fig 4C).
Interestingly, overexpression of human C9orf72 per se significantly
increased the number of mCherry-FIP200 puncta, indicating that
increasing C9orf72 levels drives translocation of the ULK1 complex
in absence of autophagy activators (Fig 4C). To test this further, we
overexpressed C9orf72 in HeLa cells and monitored mCherry-FIP200
translocation. Overexpression of either C9orf72 isoform significantly
increased the number of mCherry-FIP200 puncta to similar levels as
found after Torin1 treatment (Fig 4D). Thus, C9orf72 is required for
translocation of the ULK1 complex in cell lines and primary
neurons.
In yeast, Ypt1 (the yeast homolog of Rab1) regulates transloca-
tion of Atg1 (ULK1 in mammals) to the phagophore (Lynch-Day
et al, 2010; Wang et al, 2013). To determine whether this was also
the case in mammalian cells, we investigated mCherry-FIP200
translocation in HeLa cells and SH-SY5Y neuroblastoma cells in
which we depleted Rab1a by siRNA—we chose Rab1a because it
had been shown to regulate autophagy in mammalian cells
(Winslow et al, 2010; Mukhopadhyay et al, 2011) and because we
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had identified Rab1a as a potential binding partner of C9orf72 by
yeast 2 hybrid (Y2H, Fig 6A). Thus, our data suggested that C9orf72
might act with Rab1a to regulate translocation of the ULK1 complex
and induce autophagy. To investigate this possibility, we quantified
the induction of ULK1 complex translocation and autophagy elicited
by increased C9orf72S or C9orf72L expression in Rab1a siRNA-
treated HeLa and SH-SY5Y neuroblastoma cells. Rab1a siRNA
completely prevented translocation of mCherry-FIP200 induced by
Torin1, confirming its role in ULK1 complex trafficking (Fig 5A and
B). Overexpression of C9orf72S or C9orf72L no longer induced
translocation of mCherry-FIP200 in Rab1a siRNA-treated cells, and
the number of C9orf72-induced EGFP-LC3-positive autophagosomes
was significantly reduced (Fig 5A–C). In an alternative approach,
we used dominant negative (DN) Rab1a to inhibit Rab1a in HeLa
cells expressing Myc-C9orf72S or C9orf72L and monitored mCherry-
FIP200 and EGFP-LC3. Again inhibition of Rab1a function reduced
mCherry-FIP200 translocation and autophagosome formation
elicited by increased C9orf72S or C9orf72L expression (Fig EV3).
Thus, C9orf72 regulates Rab1a-dependent trafficking of the ULK1
complex.
C9orf72 interacts with Rab1a
Our data and the structural homology of C9orf72 with DENN
domain proteins that are GEFs for Rab GTPases (Zhang et al, 2012;
Levine et al, 2013) suggested that C9orf72 might interact with
Rab1a. Consistent with a direct interaction, we isolated a partial
Rab1a clone (aa 46–205) in a Y2H screen of a human brain cDNA
library with C9orf72S as “bait” (Fig 6A). To test this interac-
tion further, we first transfected HEK293 cells with Myc-tagged
Rab1a and FLAG-tagged C9orf72S or C9orf72L and performed
co-immunoprecipitation assays. Secondly, we immunoprecipitated
transfected Myc-tagged C9orf72S or C9orf72L and probed the result-
ing immune pellet for endogenous Rab1a. In both assays, Rab1a
co-immunoprecipitated efficiently with C9orf72L and to a lesser
extent with C9orf72S (Fig 6B and C).
We next asked whether C9orf72 interacted with Rab1a in
in vitro binding assays. We incubated recombinant GST-tagged
C9orf72 with in vitro-translated 35S-radiolabeled Rab1a and pulled
down GST-C9orf72 using glutathione beads. Rab1a interacted with
both C9orf72L and C9orf72S in these assays (Fig 6D). Preloading
Rab1a with GDP to mimic inactive Rab1a did not alter binding to
C9orf72, but preloading Rab1a with the non-hydrolysable GTP
analog GMP-PNP to mimic activated Rab1a increased interaction of
Rab1a with C9orf72S and C9orf72L two- and fourfold, respectively
(Fig 6D). To further validate the specificity of the C9orf72–Rab1a
interaction, we performed an equilibrium binding experiment using
increasing concentrations of radiolabeled C9orf72 protein and a
constant amount of GST-Rab1a. There was no binding to the
GST-negative pull-down control and increased binding of C9orf72
to GST-Rab1a with increasing concentrations of C9orf72 protein
added. Consistent with a specific interaction, the resulting binding
curve fitted a hyperbola (R2 = 0.94) which is characteristic of a
biological interaction (Fig 6E; Pollard, 2010). Thus, C9orf72 binds
to Rab1a and behaves as a Rab1a effector rather than a
Rab1a GEF.
C9orf72 mediates interaction of Rab1a with the ULK1 complex
We reasoned that C9orf72 may recruit activated Rab1a to the ULK1
complex to initiate translocation. To test this, we probed the interac-
tion of HA-ULK1 and Myc-Rab1a in HeLa cells treated with non-
targeting control siRNA or C9orf72 siRNA by in situ PLA. In control
siRNA-treated cells, we observed proximity signals in all cells co-
transfected with HA-ULK1 and Myc-Rab1a while in cells transfected
with HA-ULK1 or Myc-Rab1a alone only very low numbers of
proximity signals were observed. In contrast, in cells treated with
C9orf72 siRNA proximity signals were no longer detected in
HA-ULK1 and Myc-Rab1a-co-transfected cells (Fig 7A). Thus, these
data show ULK1–Rab1a interaction in intact cells and reveal that
this interaction is C9orf72 dependent.
To test the functional significance of these interactions, we trans-
fected HeLa cells that were treated with control or C9orf72 siRNA
with dominant active Rab1a(Q70L) and monitored mCherry-FIP200
translocation and EGFP-LC3-positive autophagosomes. Consistent
with the Rab1a dependency of ULK1 complex translocation, in
control siRNA-treated cells Rab1a(Q70L) induced translocation of
mCherry-FIP200 and Rab1a(Q70L) appeared punctate and co-
localized with FIP200-positive structures. In contrast, in C9orf72
siRNA-treated cells Rab1a(Q70L) appeared more uniformly distrib-
uted in the cytoplasm and did not induce FIP200 translocation
(Fig 7B). Similarly, overexpression of Rab1a(Q70L) increased the
Figure 3. C9orf72 interacts with the ULK1 initiation complex.
A–C Cell lysates of HEK293 cells co-transfected with FLAG-FIP200 (A), or HA-ULK1 (B) and either empty vector control, Myc-C9orf72S, or Myc-C9orf72L or with Myc-
ATG13 (C) and either empty vector control, FLAG-C9orf72S, or FLAG-C9orf72L were subjected to immunoprecipitation with anti-Myc (A and B) or anti-FLAG (C)
antibodies. Immune pellets were probed for Myc-C9orf72 (A and B), FLAG-C9orf72 (C), FLAG-FIP200 (A), HA-ULK1 (B), or Myc-ATG13 (C) on immunoblots.
D, E Cell lysates of HEK293 cells transfected with empty vector control, Myc-C9orf72S, or Myc-C9orf72L were subjected to immunoprecipitation with anti-Myc
antibodies. Immune pellets were probed for Myc-C9orf72 and endogenous FIP200, ULK1, and ATG13. There are multiple alternatively spliced forms of ATG13 (Jung
et al, 2009; Alers et al, 2011); ATG13* is most likely a smaller alternative spliced form of ATG13 that is enriched by interaction with C9orf72.
F–H HeLa cells transfected with HA-ULK1 or Flag-FIP200 and Myc-C9orf72 or with Myc-ATG13 and EGFP-C9orf72 were fixed and processed for PLA analysis.
Transfections were laced with mVenus to enable identification of transfected cells for analysis where required (green). PLA signals (red) were counted per cell
(mean  SEM; one-way ANOVA with Fisher’s LSD test, ****P ≤ 0.0001; N (cells) = (F) C9orf72S: 22; C9orf72L: 18; EV+FIP200: 18; C9orf72S+FIP200: 18;
C9orf72L+FIP200: 17; (G) C9orf72S: 21; C9orf72L: 20; EV+ULK1: 20; C9orf72S+ULK1: 22; C9orf72L+ULK1: 20; (H) C9orf72S: 11; C9orf72L: 10; EV+ATG13: 11;
C9orf72S+ATG13: 11; C9orf72L+ATG13: 11). Scale bar = 10 lm; see also Fig EV2.
I–K 35S-radiolabeled recombinant FIP200-6xHis segments (I), Myc-ATG13 (J), or HA-ULK1 (K) were added to GST, GST-C9orf72S, and GST-C9orf72L immobilized on
glutathione-coated beads. 35S-radiolabeled recombinant proteins were visualized by phosphorimager (top panels). Coomassie-stained GST, GST-C9orf72S, and GST-
C9orf72L in the pull-down samples are shown (bottom panels). The identity of the Coomassie protein bands was confirmed by mass spectrometry (# indicates
E. coli DnaK chaperonin; * indicates E. coli 60kD chaperonin; Appendix Fig S3).
Source data are available online for this figure.
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number of autophagosomes in control siRNA-treated cells but not in
C9orf72 siRNA-treated cells (Fig 7C).
In conclusion, these data are consistent with a model in which
C9orf72 acts as an effector of Rab1a that recruits active Rab1a to the
ULK1 complex to promote translocation of the ULK1 complex to the
phagophore during autophagy initiation.
C9orf72 depletion induces p62 accumulation
C9ALS/FTD appears to involve haploinsufficiency of C9orf72
(DeJesus-Hernandez et al, 2011; Cooper-Knock et al, 2012;
Gijselinck et al, 2012, 2015; Belzil et al, 2013; Ciura et al, 2013;
Donnelly et al, 2013; Mori et al, 2013b; Xi et al, 2013; Waite et al,
2014). Our data predict that C9orf72 haploinsufficiency would
impair autophagy. In agreement with this, C9ALS/FTD patients
show characteristic p62-positive, neuronal cytoplasmic and intranu-
clear inclusions in the cerebellum and hippocampus (Al-Sarraj et al,
2011; Cooper-Knock et al, 2012; Mackenzie et al, 2014). To further
investigate whether loss of C9orf72 is sufficient to cause p62 alter-
ations consistent with the pathology in patients, we monitored
endogenous p62 by immunofluorescence in C9orf72 siRNA-treated
HeLa cells and in primary cortical neurons transduced with C9orf72
miRNA. p62-positive puncta accumulated in both HeLa and primary
neurons depleted of C9orf72 when compared to non-targeting
control (Fig 8A and B). This accumulation was directly caused by
loss of C9orf72 because reintroducing C9orf72 by transduction with
human C9orf72 reduced the number of p62 puncta back to control
level in C9orf72 miRNA knockdown rat cortical neurons (Fig 8B).
Thus, loss of C9orf72 mimics C9ALS/FTD p62 pathology in vitro.
Basal levels of autophagy are reduced in C9ALS/FTD patient-
derived iNeurons
To further test the possible involvement of C9orf72 haploinsuffi-
ciency in C9ALS/FTD, we analyzed basal levels of autophagy in
C9ALS/FTD patient-derived iNeurons. iNeurons were obtained by
differentiation of iNPCs of two C9ALS/FTD patients and age- and
gender-matched controls (Meyer et al, 2014) (Appendix Table S1).
As iNPCs are not clonally expanded, they do not display clonal
variability. We confirmed the levels of C9orf72 in these cells by
RT–qPCR. Compared to the controls, all C9ALS/FTD cases showed a
marked reduction in C9orf72, which is consistent with previous
reports of haploinsufficiency in patient material (Appendix Fig S4).
Both LC3-I and II were detectable in the controls and LC3-II accumu-
lated upon treatment with bafilomycin A1 (Figs 9A and B).
Untreated C9ALS/FTD cases displayed higher levels of LC3-I
compared to their controls, but LC3-II levels were similar. Upon
treatment with bafilomycin A1, LC3-II levels accumulated to detect-
able levels in the C9ALS/FTD cases, but the levels of LC3-II
remained significantly below those found in bafilomycin A1-treated
controls. Thus, while autophagy was not completely blocked, there
was a marked reduction of autophagy in C9ALS/FTD iNeurons
compared to control iNeurons (Fig 9A and B).
Discussion
We show that C9orf72 interacts with Rab1a and the ULK1 complex
and mediates interaction of Rab1a with the ULK1 initiation complex
to facilitate its trafficking to the phagophore and initiate autophago-
some formation. Our data are in contrast to a previous report indi-
cating an increase in LC3-II in C9orf72 siRNA-treated SH-SY5Y cells
which suggests a possible late autophagy defect (Farg et al, 2014).
Our experiments in HEK293, HeLa, and SH-SY5Y cells and in
primary rat cortical neurons did not yield any evidence for involve-
ment of C9orf72 in the late steps of autophagy. All our data firmly
point toward a role of C9orf72 in autophagy initiation: (i) auto-
phagic flux assays using multiple inducers and readouts in multiple
cell lines and primary neurons show effects consistent with initia-
tion defects in C9orf72 knockdown cells (Fig 1), (ii) overexpression
of C9orf72 induces autophagy in a FIP200-dependent way (Fig 2),
(iii) C9orf72 interacts with FIP200, ULK1, and ATG13 in the ULK1
initiation complex in vitro and in cells (Fig 3), (iv) C9orf72 interacts
with Rab1a in Y2H, in vitro and in cells to regulate translocation of
the ULK1 complex which is known to be essential for autophagy
initiation (Figs 4–7), and (v) our data in iNeurons give no indication
for block in the later stages of autophagy (Fig 9).
In silico sequence analysis revealed that C9orf72 shows structural
homology to DENN family proteins which function as GEFs for Rab
GTPases (Zhang et al, 2012; Levine et al, 2013). Recent work has
Figure 4. C9orf72 regulates translocation of the ULK1 complex.
A HEK293 cells were transfected with non-targeting (Ctrl) or C9orf72 siRNA. Cells were treated with rapamycin for 6 h to induce autophagy. Activation of ULK1 was
determined on immunoblots using phospho-ULK1 (Ser757), total ULK1, and GAPDH Abs (loading control).
B HeLa cells treated with non-targeting (Ctrl) or C9orf72 siRNA were transfected with mCherry-FIP200. Twenty-four hours post-transfection, cells were treated for 3 h
with Torin1 (250 nM) or vehicle (Ctrl). Translocation of the ULK1 complex was quantified as the number of mCherry-FIP200-positive puncta per cell from 3
independent experiments (mean  SEM; one-way ANOVA with Fisher’s LSD test, ns: not significant, ****P ≤ 0.0001; N (cells) = Ctrl/Ctrl: 65; Ctrl/Torin1: 60; C9orf72/
Ctrl: 54; C9orf72/Torin1: 49). C9orf72 knockdown was determined by RT–qPCR (Appendix Fig S2). Scale bar = 10 lm.
C Primary cortical neurons (DIV5/6) were transfected with EmGFP non-targeting (Ctrl) or C9orf72 miRNA (green) and mCherry-FIP200 (red); for rescue experiments, the
cells were additionally transfected with mCerulean-tagged C9orf72s and C9orf72L (cyan). Three days post-transfection, neurons were treated for 3 h with Torin1
(250 nM) or vehicle (Ctrl). Translocation of the ULK1 complex was quantified as the number of mCherry-FIP200-positive puncta per soma from 2 independent
experiments (mean  SEM; one-way ANOVA with Fisher’s LSD test, ns: not significant, ***P ≤ 0.001, ****P ≤ 0.0001; N (cells) = Ctrl miRNA/Ctrl: 134; Ctrl miRNA/
Torin1: 125; C9orf72 miRNA/Ctrl: 101; C9orf72 miRNA/Torin1: 78; C9orf72 miRNA+C9orf72L+C9orf72S: 41; C9orf72 miRNA+C9orf72L+C9orf72S/Torin1: 39). Scale
bar = 5 lm.
D HeLa cells were co-transfected with mCherry-FIP200 (red) and empty vector (EV), FLAG-C9orf72L, or FLAG-C9orf72S (green). As positive control, EV-transfected cells
were treated for 3 h with Torin1 (250 nM). Translocation of the ULK1 complex was quantified as the number of mCherry-FIP200-positive puncta per cell from 3
independent experiments (mean  SEM; one-way ANOVA with Fisher’s LSD test, ***P ≤ 0.001, ****P ≤ 0.0001; N (cells) = EV: 47, EV+Torin1: 31, C9orf72L: 46,
C9orf72S: 45). Scale bar = 10 lm.
Source data are available online for this figure.
◀
The EMBO Journal Vol 35 | No 15 | 2016 ª 2016 The Authors
The EMBO Journal C9orf72 regulates initiation of autophagy Christopher P Webster et al
1664
Published online: June 22, 2016 
ACtrl RabsiRNA: 
EV C9orf72L C9orf72STorin1
0
10
20
30
40
FI
P2
00
 p
un
ct
a 
pe
r c
el
l
****
**** ****
****
**** ****
Ctrl Rab Ctrl Rab Ctrl Rab
M
yc
-C
9o
rf7
2
m
C
he
rr
y 
FI
P
20
0
M
er
ge
CTRL siRNA
EV +Torin1 C9orf72L C9orf72S
Rab1a siRNA
EV +Torin1 C9orf72L C9orf72S
0
5
10
15
FI
P2
00
 p
un
ct
a/
ce
ll
****
****
****
**** ****
ns
**
Ctrl RabsiRNA: 
EV C9orf72L C9orf72STorin1
Ctrl Rab Ctrl Rab Ctrl Rab
B
m
C
he
rr
y
FI
P
20
0
M
yc
-C
9o
rf7
2
CTRL siRNA Rab1a siRNA
M
er
ge
EV +Torin1 C9orf72L C9orf72S EV +Torin1 C9orf72L C9orf72S
C
E
G
FP
-L
C
3
M
yc
-
C
9o
rf7
2
M
er
ge
CTRL siRNA Rab1a siRNA
EV +Torin1 C9orf72L C9orf72S EV +Torin1 C9orf72L C9orf72S
0
5
10
15
LC
3 
pu
nc
ta
/c
el
l
****
***
*
*** ***ns
****
Ctrl RabsiRNA: 
EV C9orf72L C9orf72STorin1
Ctrl Rab Ctrl Rab Ctrl Rab
Figure 5. C9orf72 regulates translocation of the ULK1 complex via Rab1a.
A, B HeLa cells (A) or SH-SY5Y neuroblastoma cells (B) treated with non-targeting (Ctrl) or Rab1a siRNA were co-transfected with mCherry-FIP200 (red) and empty
vector (EV), Myc-C9orf72L, or Myc-C9orf72S (green). As positive control, EV-transfected cells were treated for 3 h with Torin1 (250 nM). Translocation of the ULK1
complex was quantified as the number of mCherry-FIP200-positive puncta per cell [A, HeLa, mean  SEM; one-way ANOVA with Fisher’s LSD test; ns, not
significant; ****P ≤ 0.0001; N (cells from 3 independent experiments) = Ctrl/EV: 81; Ctrl/EV/Torin1: 48; Ctrl/C9orf72L: 86; Ctrl/C9orf72S: 48; Rab1a/EV: 79; Rab1a/EV/
Torin1: 68; Rab1a/C9orf72L: 78; Rab1a/C9orf72S: 52; B, SH-SY5Y: mean  SEM; one-way ANOVA with Fisher’s LSD test; ns, not significant; **P ≤ 0.01; ****P ≤ 0.0001;
N (cells from 2 independent experiments) = Ctrl/EV: 70; Ctrl/EV/Torin1: 56; Ctrl/C9orf72L: 45; Ctrl/C9orf72S: 43; Rab1a/EV: 63; Rab1a/EV/Torin1: 55; Rab1a/C9orf72L:
44; Rab1a/C9orf72S: 37]. Rab1a knockdown was confirmed by RT–qPCR (Appendix Fig S2). Scale bar = 10 lm.
C SH-SY5Y neuroblastoma cells treated with non-targeting (Ctrl) or Rab1a siRNA were co-transfected with EGFP-LC3 (green) and empty vector (EV), Myc-C9orf72L, or
Myc-C9orf72S (red). As positive control, EV-transfected cells were treated for 3 h with Torin1 (250 nM). Autophagosomes were quantified as the number of EGFP-
LC3-positive puncta per cell (mean  SEM; one-way ANOVA with Fisher’s LSD test; ns, not significant; *P ≤ 0.05, ***P ≤ 0.001, ****P ≤ 0.0001; N (cells from 2
independent experiments) = Ctrl/EV: 102; Ctrl/EV/Torin1: 92; Ctrl/C9orf72L: 97; Ctrl/C9orf72S: 76; Rab1a/EV: 102; Rab1a/EV/Torin1: 107; Rab1a/C9orf72L: 101; Rab1a/
C9orf72S: 87). Rab1a knockdown was confirmed by RT–qPCR (Appendix Fig S2). Scale bar = 10 lm.
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shown that a complex comprising C9orf72, WDR41, and SMCR8
acts as a GEF for Rab8a and Rab39b in the autophagy pathway, thus
providing functional evidence that C9orf72 is a bona fide DENN
family protein with GEF activity (Sellier et al, 2016). On the other
hand, we show here that C9orf72 binds to Rab1a (Fig 6) to regulate
trafficking of the ULK1 complex during autophagy initiation (Figs 4
and 5). Moreover, we found that C9orf72 preferentially binds to
GTP-loaded Rab1a, behavior expected of a Rab1a effector but not a
Rab1a GEF (Fig 6D). It is well established that Rab GTPases act in
so-called Rab GEF/GAP cascades in which the transition from an
upstream Rab to a downstream Rab is achieved by recruiting the
GAP and GEF for the upstream and downstream Rab GTPases as
effectors, respectively (Hutagalung & Novick, 2011; Ao et al, 2014).
Together, these data support the existence of a novel Rab GEF/GAP
cascade, in which Rab1a as upstream Rab recruits C9orf72/SMCR8/
WDR41 as a GEF of downstream Rab8a and Rab39b. As such, via
interaction with the ULK1 complex, C9orf72 may link initiation of
autophagy to downstream events. In agreement with such a model,
SMCR8 and WDR41 were also found to associate with the ULK1
complex (Behrends et al, 2010; Sullivan et al, 2016).
C9orf72 is the second Rab GTPase associated protein involved in
ALS. Alsin (ALS2), associated with juvenile ALS, is a Rab5 GEF
(Topp et al, 2004). While Rab5 is best known for its vital role in the
early endocytic pathway, similar to Rab1a, Rab5 also participates in
autophagosome formation (Ao et al, 2014). Whereas Rab1a
regulates autophagosome formation via the Atg9/Atg2–Atg18
complex and as shown here regulates trafficking of the ULK1 initia-
tion complex to the phagophore (Figs 4 and 5), Rab5 acts through
the Vps34–Atg6/beclin1 class III PI3-kinase complex (Winslow et al,
2010; Lipatova & Segev, 2012; Dou et al, 2013; Wang et al, 2013).
Thus, both C9orf72 and Alsin appear to be regulators of trafficking
events in the autophagy pathway.
In the case of ALS2, disease is caused by loss of function of Alsin,
suggesting defective autophagosome formation may be involved in
ALS pathogenesis. Several groups have found that C9orf72 mRNA
levels are reduced in C9ALS/FTD (DeJesus-Hernandez et al, 2011;
Cooper-Knock et al, 2012; Gijselinck et al, 2012, 2015; Belzil et al,
2013; Ciura et al, 2013; Donnelly et al, 2013; Mori et al, 2013b; Xi
et al, 2013) and reduced C9orf72 protein levels have been detected
in the frontal cortex of ALS and FTD cases (Waite et al, 2014; Xiao
et al, 2015). Moreover, it has been reported that C9orf72 repeat size
correlates with transcriptional downregulation of the promoter and
onset age of disease (Gijselinck et al, 2015). Accordingly, C9orf72
loss of function by haploinsufficiency has been put forward as a
possible cause of C9ALS/FTD, but this has been difficult to verify
without knowing the cellular function of C9orf72. Here, we show
that C9orf72 is required for the initiation of autophagy (Fig 1) and
that C9ALS/FTD patient-derived iNeurons have significantly
impaired basal levels of autophagy (Fig 9). Also in agreement with
defective autophagy caused by C9orf72 loss of function, C9ALS/FTD
Figure 6. C9orf72 interacts with Rab1a.
A A human brain random cDNA library was screened in a Y2H assay using C9orf72S as bait. A clone coding for aa 46–205 of Rab1a, comprising most of the GTP-binding
G-box domain and the C-terminal CC-motif was found to interact with C9orf72S.
B Cell lysates of HEK293 cells co-transfected with Myc-Rab1a and either empty vector, FLAG-C9orf72S, or FLAG-C9orf72L were subjected to immunoprecipitation with
anti-FLAG antibody. Bound protein was eluted from beads using excess FLAG peptide. Immune eluates were probed for FLAG-C9orf72 and Myc-Rab1a on
immunoblots. The input levels of FLAG-C9orf72 and Myc-Rab1a in the transfected cells are shown (Inputs). * indicates remaining Myc-Rab1a signal after reprobing
for FLAG-C9orf72.
C Cell lysates of HEK293 cells transfected with Myc-C9orf72S or Myc-C9orf72L were subjected to immunoprecipitation with anti-Myc antibody. The resulting immune
pellet was probed for endogenous Rab1a.
D 35S-radiolabeled recombinant Myc-Rab1a protein loaded with vehicle, GDP or GMP-PNP was added to GST, GST-C9orf72S, and GST-C9orf72L immobilized on
glutathione-coated beads. 35S-radiolabeled recombinant Myc-Rab1a protein was visualized by phosphorimager (top panel). Coomassie-stained GST, GST-C9orf72S,
and GST-C9orf72L in the pull-down samples are shown (bottom panel). The identity of the Coomassie protein bands was confirmed by mass spectrometry (# indicates
E. coli DnaK chaperonin; * indicates E. coli 60kD chaperonin; Appendix Fig S3). Relative binding of Rab1a to C9orf72 was quantified from 3 independent experiments
(mean  SEM; one-way ANOVA with Fisher’s LSD test; ns, not significant; *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001).
E Increasing volumes of 35S-radiolabeled recombinant Myc-C9orf72L protein were incubated with equal amounts of GST-Rab1a immobilized on glutathione-coated
beads in an equilibrium binding experiment. 8 ll of 35S-radiolabeled recombinant Myc-C9orf72L protein was incubated with GST as a negative control. Bound 35S-
radiolabeled Myc-C9orf72L protein was visualized by phosphorimager. Coomassie-stained GST-Rab1a and GST in the pull-down samples are shown. Densitometry
analysis of the amount of 35S-radiolabeled recombinant Myc-C9orf72L protein bound to GST-Rab1a in the different binding reactions was used to fit an equilibrium
binding hyperbola (R2 = 0.94).
Source data are available online for this figure.
Figure 7. C9orf72 mediates interaction of Rab1a with the ULK1 complex.
A HEK293 cells treated with non-targeting (Ctrl) or C9orf72 siRNA were transfected with HA-ULK1, Myc-Rab1a, or HA-ULK1 + Myc-Rab1a as indicated. Transfections
were laced with mVenus to enable identification of transfected cells for analysis (green). Transfected cells were probed with anti-HA and anti-Myc antibodies and
processed for PLA. PLA proximity signals (red) per cell were determined from 3 independent experiments (mean  SEM; one-way ANOVA with Fisher’s LSD test,
****P ≤ 0.0001; N (cells) = Ctrl/HA-ULK1: 125, Ctrl/Myc-Rab1a: 149, Ctrl/HA-ULK1 + Myc-Rab1a: 163, C9orf72/HA-ULK1: 136, C9orf72/Myc-Rab1a: 133, C9orf72/HA-
ULK1 + Myc-Rab1a: 155). Scale bar = 20 lm.
B HeLa cells treated with non-targeting (Ctrl) or C9orf72 siRNA were co-transfected with mCherry-FIP200 (red) and empty vector (EV) or Myc-Rab1a(Q70L) (green).
Translocation of the ULK1 complex was quantified as the number of mCherry-FIP200-positive puncta per cell from 4 independent experiments (mean  SEM; one-
way ANOVA with Fisher’s LSD test, *P ≤ 0.05, ****P ≤ 0.0001; N (cells) = Ctrl/EV: 101; Ctrl/Q70L: 106; C9orf72/Q70L: 42). C9orf72 knockdown was determined by
RT–qPCR (Appendix Fig S2). Scale bar = 10 lm.
C HeLa cells treated with non-targeting (Ctrl) or C9orf72 siRNA were co-transfected with EGFP-LC3 (green) and empty vector (EV) or Myc-Rab1a(Q70L) (red).
Autophagosomes were quantified as the number of EGFP-LC3-positive puncta per cell (mean  SEM; one-way ANOVA with Fisher’s LSD test, **P ≤ 0.01,
****P ≤ 0.0001; N (cells) = Ctrl/EV: 44; Ctrl/Q70L: 32; C9orf72/Q70L: 47). C9orf72 knockdown was determined by RT–qPCR (Appendix Fig S2). Scale bar = 10 lm.
◀
▸
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patients show specific ubiquitin and p62-positive inclusions in the
brain (Al-Sarraj et al, 2011; Cooper-Knock et al, 2012; Mackenzie
et al, 2014) and our data show that loss of C9orf72 in cells and
primary neurons mimics C9ALS/FTD p62 pathology (Fig 8). Thus,
our findings provide a molecular explanation for C9ALS/FTD p62
pathology and suggest that autophagy deficits due to C9orf72
haploinsufficiency may contribute to C9ALS/FTD. Clearly, more
work is required to assess the contribution of defective autophagy to
neuronal loss in C9ALS/FTD, but it is well established that loss of
neuronal autophagy can cause neurodegeneration. Neuron-specific
knockout of the essential autophagy genes ATG7, ATG5, and
RB1CC1 (FIP200) in mice causes neurodegeneration, progressive
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Figure 8. Loss of C9orf72 induces p62 accumulation.
A HeLa cells treated with non-targeting (Ctrl) or C9orf72 siRNA were immunostained for endogenous p62. Accumulation of p62 was quantified by counting p62-positive
puncta per cell from 3 independent experiments (mean  SEM; unpaired t-test, ****P ≤ 0.0001; N (cells) = Ctrl: 74, C9orf72: 55). C9orf72 knockdown was confirmed
by RT–qPCR (Appendix Fig S2). Scale bar = 10 lm.
B Primary cortical neurons (DIV5) were transduced with 4TU/cell EmGFP non-targeting control miRNA (Ctrl) or C9orf72 miRNA (green); for rescue experiments, the cells
were additionally transduced with 4TU/cell mVenus-tagged C9orf72s and C9orf72L (verified by immunoblot, Appendix Fig S2). Neurons were immunostained for
endogenous p62 3 days post-transduction. Accumulation of p62 was quantified by counting p62-positive puncta per soma from 2 independent experiments
(mean  SEM; one-way ANOVA with Fisher’s LSD test, **P ≤ 0.01; N (cells) = Ctrl miRNA: 80; C9orf72 miRNA: 80; C9orf72 miRNA+C9orf72L+C9orf72S: 75). Scale
bar = 10 lm.
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deficits in motor function, including abnormal limb-clasping reflexes
(as also observed in ALS-SOD1 mice) and a reduction in coordinated
movement, that are accompanied by the accumulation of cytoplas-
mic inclusion bodies in neurons (Hara et al, 2006; Komatsu et al,
2006; Liang et al, 2010). In these neuronal autophagy-deficient
mice, the cerebellum is particularly affected suggesting that the cere-
bellum is singularly reliant on autophagy (Hara et al, 2006;
Komatsu et al, 2006; Liang et al, 2010). Similarly, in C9ALS/FTD
patients ubiquitin/p62-positive/TDP43-negative pathology appears
to be largely restricted to the cerebellum and hippocampus (Al-
Sarraj et al, 2011; Cooper-Knock et al, 2012; Mackenzie et al,
2014). Knockout of C9orf72 in mice did not cause motor neuron
degeneration or motor deficits (Koppers et al, 2015; Atanasio et al,
2016; O’Rourke et al, 2016; Sudria-Lopez et al, 2016; Sullivan et al,
2016), indicating that in contrast to ATG7, ATG5, and RB1CC1
(FIP200), C9orf72 is not essential for all autophagy in mice. Alterna-
tively, there may be redundancy of the C9orf72 gene in mammalian
species. Full knockout of C9orf72 did cause altered immune
responses in macrophages and microglia, suggesting C9orf72 regu-
lates immune homeostasis (Atanasio et al, 2016; O’Rourke et al,
2016; Sudria-Lopez et al, 2016; Sullivan et al, 2016). The role of
autophagy in the immune system is well established (Shibutani
et al, 2015); thus, possibly C9orf72 plays a specific role in immune-
related autophagy initiation. Consistent with defective autophagy,
these C9orf72 knockout mice showed lysosomal accumulation and
increased amounts of p62 and both LC3-I and II in homozygote
spleens (O’Rourke et al, 2016; Sullivan et al, 2016). However, since
both LC3-I and II were increased, this is not likely to be due to a
block in late autophagy as suggested by O’Rourke et al (2016) but
rather a compensatory increase in response to decreased autophagy
initiation. Indeed, we observed a similar increase of LC3-I in
patient-derived iNeurons (Fig 9) and in C9orf72 knockout zebrafish
and mice (data not shown).
Impaired autophagy has also been implicated in non-C9orf72
ALS/FTD and other neurodegenerative diseases (Chen et al, 2012;
Harris & Rubinsztein, 2012). Abnormal autophagy has been found
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Figure 9. C9ALS/FTD iNeurons exhibit autophagy deficits.
A, B Two C9ALS/FTD iNeuron cultures (201 in A and 183 in B) and their matching controls (209 in A and 155 in B) were treated with vehicle (Ctrl) or bafilomycin A1
(BafA1, 100 nM; 6 h) and processed for immunoblot detection of LC3. LC3-II levels were normalized to a-tubulin (mean  SEM; one-way ANOVA with Fisher’s LSD
test; ns, not significant; *P ≤ 0.05; **P ≤ 0.01; ****P ≤ 0.0001; Ctrl 209/Pat 201, n = 4; Ctrl 155/Pat 183, n = 6).
Source data are available online for this figure.
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in SOD1 and TDP43 models of ALS, and as mentioned above, Alsin
may regulate autophagy via Rab5. Furthermore, several ALS/FTD
genes, such as charged multivesicular body protein-2B (CHMP2B),
valosin-containing protein (VCP), ubiquilin 2, p62 (sequestosome
1), optineurin, and TANK-binding kinase (TBK1), are directly linked
to autophagy. Thus, neurodegeneration associated with defective
neuronal autophagy appears to be intimately linked with ALS/FTD,
reinforcing autophagy as a possible therapeutic target for ALS/FTD.
Materials and Methods
Plasmids
C9orf72L and C9orf72S cDNA was generated by PCR using Phusion
High Fidelity enzyme (NEB) from a HEK293 cDNA library prepared
in house, using primers containing restriction sites. The Myc- and
FLAG-tagged constructs were cloned by standard subcloning tech-
niques into pRK5-Myc and p3xFLAG-CMV, using SalI/NotI and
HindIII/BamHI restriction sites, respectively. GST-tagged C9orf72S
and C9orf72L constructs were generated by subcloning into
pGEX6p1 (GE Healthcare Life Sciences) using XhoI/NotI sites. EGFP-
tagged C9orf72S and C9orf72L were generated by EcoRI/BamHI
subcloning into pEGFPc2. mVenus-tagged C9orf72S and C9orf72L
were generated by XhoI/NotI subcloning into pCI-Neo-mVenus-N, a
modified pCI-neo vector containing mVenus cDNA, generated by
PCR using Phusion High Fidelity enzyme from prSETB-mVenus (a
gift from Atsushi Miyawaki, RIKEN, Japan). mVenus-C9orf72 was
subcloned into pLvos, a modified pL-SIN-PGK-cPPT-GDNF-WHV
lentiviral vector (De´glon et al, 2000; Suzuki et al, 2007) in which the
original NheI and NotI sites were destroyed and the GDNF cDNA
was replaced by a pCI-neo-derived multiple cloning site (50-gat cct
aat acg act cac tat agg gcg gct agc ctc gag aat tca cgc gtc gcc ggc gca
tat gct gca gcc cgg gcg gcc gct tcc ctt tag tga ggg tta atg-30) using the
NheI/NotI sites to yield pLvos-mVenus-C9orf72. pL-SIN-PGK-cPPT-
EGFP-WHV was a kind gift from M. Azzouz, SITraN, Sheffield UK
(Nanou et al, 2013). p3xFLAG-CMV10-hFIP200 was a gift from
Noboru Mizushima, Tokyo Medical and Dental University, Japan,
via Addgene (plasmid #24300) (Hara et al, 2008). FIP200-6xHis frag-
ments were generated by PCR using Phusion High Fidelity enzyme
(primers: FIP200-FW: ctcgaggccacc-atgaagttatatgtatttctggtta FIP200-
638-R gcggccgctcaatggtggtggtgatgatg-ttcactcagtagatctgtaatg FIP200-
639-FW ctcgaggccaccatg-caaaaggcatctgtgagtcag FIP200-1373-6His-R
gcggccgctcaatggtggtggtgatgatg-ttcagaaagtgactctatcaaat FIP200-1374-
FW ctcgaggccaccatg-gatcgagctcgtttgcttgag FIP200-6His-R gcggccgct-
caatggtggtggtgatgatg-ttatactttcttattccatgatacg) and transferred to pCi-
Neo (Promega) using XhoI/NotI sites. mCherry-FIP200 was a gift
from Xuejun Jiang, Memorial Sloan-Kettering Cancer Center, NYC,
USA (Ganley et al, 2009). pRK5-HA-ULK1 and pRK5-Myc-hATG13
were a gift from Do-Hyung Kim, University of Minnesota, USA, via
Addgene (plasmid #31963 and #31965) (Jung et al, 2009). pCMV-
intron Myc-Rab1aWT and Myc-Rab1aS25N were from T. He´bert,
McGill University, Canada, via Addgene (plasmid #46776 and
#46777) (Dupre et al, 2006). Rab1a(Q70L) was generated from
Rab1aWT by site-directed mutagenesis using a QuikChange Light-
ning Site-Directed Mutagenesis Kit (Agilent) according to the manu-
facturer’s instructions using 50-tgttcgaaatctttccaggcctgctgtgtccc-30 and
50-gggacacagcaggcctggaaagatttcgaaca-30 primers. mCherry-EGFP-LC3b
was a gift from Terje Johansen, University of Tromsø, Norway (Pankiv
et al, 2007). EGFP-LC3b was a gift from Chris Miller, KCL, UK. All
constructs were confirmed by sequencing.
Cell culture and transfection
HEK293, HeLa, and SH-SY5Y cells (ATCC) were cultured in
Dulbecco’s modified Eagle’s medium (DMEM, Sigma) supplemented
with 10% FBS (Biosera) and 1 mM sodium pyruvate (Sigma) in a
5% CO2 atmosphere at 37°C. Cells were transfected with plasmid
DNA using Lipofectamine 2000 reagent (Invitrogen) according to
the manufacturer’s instructions or polyethylenimine (PEI) (stock
1 mM; 3 ll/lg plasmid). HeLa, HEK293, and SH-SY5Y cells were
siRNA transfected using Lipofectamine RNAiMax or Lipofectamine
2000 (Invitrogen) according to the manufacturer’s instructions. Cells
were used for experiments 4 days after siRNA transfection.
Cortical neurons were isolated from E18 Sprague Dawley rat
embryos (Charles River) and cultured on glass coverslips coated
with poly-L-lysine in 12- or 24-well plates in neurobasal medium
supplemented with B27 supplement (Invitrogen), 100 IU/ml peni-
cillin, 100 mg/ml streptomycin, and 2 mM L-glutamine. Cortical
neurons (DIV5–6) were transfected using Lipofectamine LTX with
PLUS reagent according to the manufacturer’s instructions (Ther-
mofisher). Briefly, neurons were placed in fresh culture medium
with a DNA:PLUS:LTX ratio of 1:0.5:0.5 (0.5–1 lg DNA/100,000
cells/cm2). After 6 h, the transfection mix was replaced with condi-
tioned medium. For lentiviral transduction, neurons were exposed
to 4TU/cell in fresh culture medium overnight.
iNPC production and neuronal differentiation
Induced neural progenitor cells (iNPCs) were derived from human
skin fibroblasts as previously described (Meyer et al, 2014). Human
skin fibroblast samples were obtained from PJS from the Sheffield
tissue bank. Informed consent was obtained from all subjects before
sample collection (Study number STH16573, Research Ethics
Committee reference 12/YH/0330). Briefly, 10,000 fibroblasts were
transduced with lentiviral vectors for OCT3, Sox2, KLF4, and
C-MYC for 12 h. Forty-eight hours after transduction, the cells were
washed with PBS and fibroblast medium was replaced with NPC
medium (DMEM/F-12 with glutamax supplemented with 1% N2,
1% B27, 20 ng/ml FGF-b, 20 ng/ml EGF, and 5 lg/ml heparin.
When the cells started changing shape and form neurospheres, they
were expanded as neural rosettes. When the iNPC culture was con-
fluent (~3 weeks), EGF and heparin were withdrawn and the FGF-b
concentration increased to 40 ng/ml. The iNPCs can be maintained
for ~30 passages. iNPCs are not expanded by clone and therefore do
not display clonal variability.
For differentiation, 30,000 iNPCs were plated in a 6-well plate
coated with fibronectin (Millipore) and expanded to 70-80% conflu-
ence after which iNPC medium was replaced with neuron differenti-
ation medium (DMEM/F-12 with glutamax supplemented with 1%
N2 and 2% B27). On day one of differentiation, the cells were
treated with 2.5 lM DAPT (Tocris) to determine differentiation
toward a neuronal lineage. On day three, the neuron differentiation
medium was supplemented with 1 lM retinoic acid (Sigma), 0.5 lM
smoothened agonist (SAG) (Millipore) and 2.5 lM forskolin (Sigma)
for 7 days. This protocol leads to typical yields of 70% b-III tubulin
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(Tuj1)-positive cells. iNeuron experiments were repeated at least 3
times for each sample starting from iNPCs at different passages,
typically between passages 10 and 20 to ensure that the results
observed are not determined by batch effects or passage number.
siRNA and miRNA
Non-targeting control siRNA and targeting siRNA were purchased
from Sigma. The siRNA sequences were as follows: C9orf72#2:
gugcuauagauguaaaguu, C9orf72#D: gaucagggucagaguauua, FIP200#1
caaguuagagguugaacuu, FIP200#2 gaucuuaugugaucgucca, Rab1a#1
gaacaaucaccuccaguua, Rab1a#2 cagaucaggaguccuucaa.
miRNA targeting rat C9orf72 (miRC9orf72) was designed using
Invitrogen’s RNAi Designer (http://rnaidesigner.thermofisher.com/
rnaiexpress/) and cloned into the pcDNA6.2TM-GW/EmGFP miR
expression vector according to the manufacturer’s instructions
(BLOCK-iTTM Pol II miR RNAi expression vector kit, Invitrogen; top
strand: 50-tgc tgt atc cca gta agc aaa ggt agg ttt tgg cca ctg act gac cta
cct ttt tac tgg gat a-30). pcDNA6.2TM-GW/ECFP miR was generated by
replacing EmGFP with ECFP in pcDNA6.2TM-GW/EmGFP. EmGFP
miRC9orf72 was amplified from pcDNA6.2TM-GW using 50-gct agc aca
agt ttg tac aaa aaa gca-30 and 50-gcg gcc gcc aac cac ttt gta caa gaa agc
t-30 primers and subcloned into pLvos using XhoI/NotI sites. Non-
targeting miRNA is part of the BLOCK-iTTM Pol II miR RNAi expression
vector kit.
Lentiviral production
3 × 106 HEK293T cells (ATCC) were seeded per 10-cm dish and
transfected with 12.5 lg of DNA the following day (4.95 lg of pL
expression constructs, 4.95 lg pCMV-dR8.92 (a gift from Bob Wein-
berg via Addgene (plasmid #8455)) (Stewart et al, 2003), 1.45 lg
pMD2.G, and 1.15 lg pRSV-Rev (both from Didier Trono via
Addgene (plasmid #12253 and #12259) (Dull et al, 1998)) using
polyethyleneimine (PEI, 1 mg/ml; PolySciences) at a ratio of 1:3
(DNA:PEI). Cells were incubated for 72 h, and virus particles were
harvested by ultracentrifugation of the cell culture supernatants
(90 min at 65,000 g, rotor SW-28, OptimaTM L-100 K Ultracentrifuge,
Beckman Coulter). Viral pellets were resuspended in 1% BSA/PBS,
and aliquots were stored at 80°C. In order to titer the viruses,
HeLa cells were seeded into 12-well plates at a density of 75,000
cells per well and transduced with 500 ll of a 102, 103, and 104
dilution of the virus the next day. After 72 h, cells were trypsinized
and fixed (4% formaldehyde/PBS) and EGFP or mVenus fluores-
cence was analyzed by fluorescence-activated cell sorting (FACS;
BDTM LSR II Flow Cytometer). The following formula was used to
calculate the number of TU/ml: number of cells before transduc-
tion/percentage of positive gated cells × dilution factor × 2.
SDS–PAGE and immunoblotting
Cells were harvested in trypsin/EDTA (Lonza) and pelleted at 400 g
for 4 min. Pellets were washed once with phosphate-buffered saline
(PBS). Cells were lysed on ice for 30 min in ice-cold RIPA buffer
(50 mM Tris–HCl pH 6.8, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA,
0.1% (w/v) SDS, 0.5% (w/v) deoxycholic acid, 1% (w/v) Triton
X-100, and protease inhibitor cocktail (Thermo Scientific)). Lysates
were clarified at 15,000 g for 30 min at 4°C. Protein concentration
was measured by Bradford protein assay (Bio-Rad). Proteins were
separated by SDS–PAGE and transferred to nitrocellulose
membranes (Whatmann) by electroblotting (Bio-Rad). After trans-
fer, membranes were blocked for 1 h at room temperature in Tris-
buffered saline (TBS) with 5% fat-free milk (Marvel) and 0.1%
Tween-20. Membranes were incubated with primary antibodies in
blocking buffer for 1 h at room temperature or overnight at 4°C.
Membranes were washed 3 times for 10 min in TBS with 0.1%
Tween-20 before incubation with secondary antibodies in block
buffer for 1 h at room temperature. After washing, membranes were
prepared for chemiluminescent signal detection with SuperSignal
West Pico Chemiluminescent substrate (Thermo Scientific) accord-
ing to the manufacturer’s instructions. Signals were detected with a
SynGene Gbox or on ECL film (GE Healthcare). Signal intensities
were quantified using ImageJ (Abramoff et al, 2004).
Immunoprecipitation
Cells were harvested in trypsin/EDTA and pelleted at 400 g for
4 min. Pellets were washed once with phosphate-buffered saline
(PBS). Cells were lysed at 4°C for 1 h in ice-cold BRB80 lysis buffer
(80 mM K-PIPES pH 6.8, 1 mM MgCl2, 1 mM EDTA, 1% (w/v)
NP-40, and protease inhibitor cocktail). Lysates were clarified at
15,000 g for 30 min at 4°C. 2 mg of protein was incubated with
2 lg of primary antibody for 16 h at 4°C. Antibody was then
captured by incubation with 25 ll of 50% protein G-Sepharose
(Sigma) for 2 h at 4°C. After centrifuging at 3,000 g, immune
pellets were washed 5 times in ice-cold lysis buffer. Protein was
eluted from protein G beads in 2× Laemmli buffer. Samples were
analyzed by SDS–PAGE and immunoblot.
In vitro binding assays
[35S]-methionine-labeled FIP200 fragments, HA-ULK1, Myc-ATG13,
and Myc-Rab1a were produced using the T7/SP6 TnT Quick
Coupled Transcription/Translation kit (Promega). GST, GST-
C9orf72S, and GST-C9orf72L were expressed from the pGEX6p1
vector in Rossetta PLysS cells. 0.1 g GST cell pellet and 0.25 g GST-
C9orf72 cell pellets were lysed by sonication in 1 ml of buffer
RB100 (25 mM Hepes (pH 7.5), 100 mM KOAc, 10 mM MgCl2,
1 mM DTT, 0.05% Triton X-100, 10% (vol/vol) glycerol), and GST-
tagged proteins bound to 30 ll of glutathione-agarose (GSH) bead
slurry. Binding reactions were carried out in 400 ll buffer RB100
containing the 30 ll GSH beads and bound proteins along with 8 ll
of labeled protein. In case of Myc-Rab1a, 1 mM GDP or 1 mM GMP-
PNP (guanosine 50-[b,c-imido]triphosphate trisodium salt hydrate)
was added to the binding assays as indicated. Proteins were eluted
from GSH beads using glutathione elution buffer (50 mM Tris–HCl
(pH 7.5), 100 mM NaCl, 40 mM reduced glutathione) and analyzed
by SDS–PAGE. 1 ll reticulocyte lysate was loaded as input. Cells
were stained with Coomassie to show GST-tagged proteins and 35S
radiolabel was detected using a Typhoon Phosphorimager (GE
Healthcare).
Antibodies
Primary antibodies used were as follows: rabbit anti-human Tuj1
(Covance, IF: 1:500), mouse anti-FLAG (M2, Sigma, WB: 1:2,000,
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IF: 1:1,000), mouse anti-Myc (9B11, Cell Signaling, WB: 1:2,000, IF:
1:2,000), mouse anti-tubulin (DM1A, Sigma, WB: 1:10,000), rabbit
anti-Myc (ab9106, Abcam, WB: 1:2,000, IF: 1:1,000), rabbit anti-
GAPDH (14C10, Cell Signaling, WB: 1:2,000), rabbit anti-LC3 (2220,
Novus Biologicals, WB: 1:1,000), mouse anti-p62 (610833, BD Bio-
sciences, IF: 1:1,000), rabbit anti-p62 (18420-1-AP, ProteinTech, IF:
1:200), rabbit anti-FIP200 (SAB4200135, Sigma, WB: 1:500), rabbit
anti-ULK1 (#8054, Cell Signaling, WB: 1:1,000), rabbit anti-
phospho-ULK S757 (#6888, Cell Signaling, WB: 1:1,000), mouse
anti-EGFP (JL8, Clontech, WB: 1:5,000), rabbit anti-ATG13 (#6940,
Cell Signaling, WB: 1:1,000), rabbit anti-Rab1a (Ab97956 Abcam,
WB: 1:1,000), and rabbit anti-HA (Sigma, WB: 1:2,000, IF: 1:1,000).
Secondary antibodies used for immunoblotting were horseradish
peroxidase-coupled goat anti-rabbit, goat anti-rat, and rabbit anti-
mouse IgG (Dako; 1:5,000). Secondary antibodies used for
immunofluorescence were Alexa fluorophore (488, 568, or 633)-
coupled goat/donkey anti-mouse IgG, Alexa fluorophore (488, 568,
or 633)-coupled goat/donkey anti-rabbit IgG (Invitrogen; 1:500).
RNA extraction and RT–qPCR
RNA was extracted from HEK293, HeLa, SH-SY5Y, rat cortical
neurons, or iNeuron cells using TRIzol reagent (Invitrogen), accord-
ing to the manufacturer’s instructions. Extracted RNA was dissolved
in 20 ll of nuclease-free water. RNA from whole-cell extraction was
reverse-transcribed into cDNA using Superscript III reverse tran-
scriptase (Invitrogen). 2 lg RNA was transcribed in a final volume
of 10 ll with 2 ll of 25 mM dNTP mix (NEB), 4 ll of 5× reverse
transcriptase buffer (Invitrogen), 2 ll of 0.1 M DTT, 1 ll of Super-
script III, and 1 ll of Oligo(dT) (Thermo Scientific). RT–qPCR was
performed using the Stratagene Mx3000P and MxPro v4.10 soft-
ware. Samples were amplified in triplicate in 20 ll volumes using
SYBR-Green master mix and 250 nM of each optimized forward and
reverse primer. Cycling conditions for RT–qPCR were as follows:
95°C for 10 min to denature followed by 35 cycles of 95°C for 30 s,
60°C for 1 min. Levels of mRNA were quantified relative to GAPDH
mRNA levels according to the DDCt method.
Primer sequences were as follows: human C9orf72 (all isoforms),
FW gttgatagattaacacatataatccgg, REV cagtaagcattggaataatactctga;
human Rab1a, FW tgtccagcatgaatcccgaa, REV ggcaagactttccaacccct;
human GAPDH, FW gggtggggctcatttgcaggg, REV tgggggcatcagca
gagggg; rat GAPDH FW: tgaagggtggggccaaaagg, REV ggtcatgagcccttc
catga; and rat C9orf72 FW: gtgttgacaggctaacgcac, REV: agggatgacc
tccccagtaa.
Induction of autophagy
Autophagy was induced by incubation with 500 nM rapamycin for
6 h or 250 nM Torin1 for 3 h. Autophagy was blocked by addition
of 100 nM bafilomycin A1 for 5 (neurons) or 6 h. Where cells were
treated with Torin1 and bafilomycin A1, Torin1 was added 2 (neu-
rons) or 3 h after addition of bafilomycin A1.
Yeast 2 hybrid
C9orf72S was cloned as “bait” fused to the DNA binding domain of
GAL4 in pGBKT7 using EcoRI/BamHI restriction sites and was used
to screen a human brain random cDNA library. Screens were
performed by Protein Interaction Screening, Genomics and Proteo-
mics Core Facilities (W150), German Cancer Research Center
(DKFZ), Heidelberg, Germany.
Immunofluorescence
Immunostaining was performed as described previously (De Vos
et al, 2005). Briefly, cells grown on glass coverslips were fixed with
3.7% formaldehyde in phosphate-buffered saline (PBS) for 20 min
at room temperature. After washing with PBS, residual formalde-
hyde was quenched by incubation with 50 mM NH4Cl in PBS for
10 min at room temperature, followed by a second round of wash-
ing with PBS. Subsequently, the cells were permeabilized by incuba-
tion with 0.2% Triton X-100 in PBS for 3 min. Triton X-100 was
removed by washing with PBS. After fixing, the cells were incubated
with PBS containing 0.2% fish gelatin (PBS/F) for 30 min at room
temperature (cell lines) or PBS containing 2% fish gelatin for 1-2 h
(neurons) and then with the primary antibody in PBS/F for 1 h at
RT or ON at 4°C. After washing with PBS/F, the cells were incu-
bated with secondary antibody in PBS/F for 45 min at room temper-
ature and stained with Hoechst 33342. After a final wash, the
samples were mounted in fluorescence mounting medium (Dako).
Images were recorded using appropriate filtersets (Omega Optical
and Chroma Technology) using MicroManager 1.4 software
(Edelstein et al, 2014) on a Zeiss Axioplan2 microscope fitted with a
Hamamatsu C4880-80 or Retiga R3 (QImaging) CCD camera, PE-300
LED illumination (CoolLED), and a 63×, 1.4NA Plan Apochromat
objective (Zeiss) or on a Zeiss Axiovert 200 microscope equipped
with a Hamamatsu C9100-12 EMCCD, PE-4000 LED illumination
(CoolLED), and 63×, 1.4NA Plan Apochromat and 100×, 1.3NA Plan
Apochromat objectives (Zeiss) and using MetaMorph software
(Universal Imaging) on an Olympus IX83 equipped with a Zyla4.2
sCMOS camera (Andor), SpectraX light engine (Lumencor) and
OptoLED (Cairn Research) illumination, and 60×, 1.35NA Universal
Plan Super Apochromat and 40×, 1.35NA Universal Apochromat
objectives (Olympus). Illumination intensities, exposure times, and
camera settings were kept constant during experiments.
Proximity ligation assay
In situ proximity ligation assays were performed with the Duolink
In Situ Kit following the manufacturer’s protocol (Olink Bioscience).
Twenty-four hours post-transfection, cells were fixed, quenched,
and permeabilized. Samples were blocked according to the manu-
facturer’s instructions. Samples were then probed with primary
antibodies for 1 h at room temperature. After washing, cells were
incubated with mouse-minus and rabbit-plus PLA probes according
to the manufacturer’s instructions for 1 h at 37°C. After further
washes, the PLA probes were ligated for 30 min at 37°C before the
amplification step was performed for 100 min at 37°C using the
Duolink Orange detection reagents. After final washes, the samples
were mounted in fluorescence mounting medium (Dako).
Image analysis
All image analysis was performed using ImageJ (Abramoff et al,
2004). mCherry-FIP200, EGFP-LC3, mCherry-EGFP-LC3, p62 puncta,
and PLA proximity signals were counted in single cells using the
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Particle Analysis facility of ImageJ. Where possible, the cells for
analysis were selected based on fluorescence in the other channel,
else the samples were blinded to the operator. Images were filtered
using a Hat filter (7 × 7 kernel) (De Vos & Sheetz, 2007) to extract
puncta and proximity signals and thresholded such that the visible
puncta within the cell were highlighted, but no background was
included. The result of thresholding was further checked against the
original image to ensure no background signal was identified as
puncta or signals were lost. In case of mCherry-EGFP-LC3, puncta in
the red and green channels were counted separately. Red-only puncta
were determined by subtracting the green puncta from the red puncta.
Statistical analysis
Calculations and statistical analysis were performed using Excel
(Microsoft Corporation, Redmond, WA) and Prism 6 software
(GraphPad Software Inc., San Diego, CA).
Expanded View for this article is available online.
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